Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Neal

Showing results (251-260 of 260) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 260 results.
JAMA Network Open|May 25, 2023
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical TrialJeffrey S Berger, Matthew D Neal, Lucy Z Kornblith, et al.
JACC. Advances|June 28, 2024
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19Lucas C Godoy, Matthew D Neal, Ewan C Goligher, et al.
JAMA Network Open|July 15, 2020
Defining a Research Agenda for Layperson Prehospital Hemorrhage Control: A Consensus StatementEric Goralnick, Chibuike Ezeibe, Muhammad Ali Chaudhary, et al.
Annals of Internal Medicine|December 23, 2024
Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis, Claire L Vale, Peter J Godolphin, et al.
JAMA|December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial, Alisa M Higgins, Lindsay R Berry, et al.
JAMA|March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Charlotte A Bradbury, Patrick R Lawler, et al.
The New England Journal of Medicine|October 27, 2023
Simvastatin in Critically Ill Patients with Covid-19, Thomas E Hills, Elizabeth Lorenzi, et al.
Journal of Thrombosis and Haemostasis : JTH|March 27, 2026
Intermediate Dose Heparin Thromboprophylaxis among Critically Ill Patients with COVID-19: A Randomised Clinical Trial, Charlotte A Bradbury, Bryan J McVerry, et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, , , et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19, , , et al.
Pageof 26

Showing results (251-260 of 260) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 260 results.
JAMA Network Open|May 25, 2023
Effect of P2Y12 Inhibitors on Organ Support-Free Survival in Critically Ill Patients Hospitalized for COVID-19: A Randomized Clinical TrialJeffrey S Berger, Matthew D Neal, Lucy Z Kornblith, et al.
JACC. Advances|June 28, 2024
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19Lucas C Godoy, Matthew D Neal, Ewan C Goligher, et al.
JAMA Network Open|July 15, 2020
Defining a Research Agenda for Layperson Prehospital Hemorrhage Control: A Consensus StatementEric Goralnick, Chibuike Ezeibe, Muhammad Ali Chaudhary, et al.
Annals of Internal Medicine|December 23, 2024
Anticoagulation Among Patients Hospitalized for COVID-19 : A Systematic Review and Prospective Meta-analysis, Claire L Vale, Peter J Godolphin, et al.
JAMA|December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial, Alisa M Higgins, Lindsay R Berry, et al.
JAMA|March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial, Charlotte A Bradbury, Patrick R Lawler, et al.
The New England Journal of Medicine|October 27, 2023
Simvastatin in Critically Ill Patients with Covid-19, Thomas E Hills, Elizabeth Lorenzi, et al.
Journal of Thrombosis and Haemostasis : JTH|March 27, 2026
Intermediate Dose Heparin Thromboprophylaxis among Critically Ill Patients with COVID-19: A Randomised Clinical Trial, Charlotte A Bradbury, Bryan J McVerry, et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19, , , et al.
The New England Journal of Medicine|August 5, 2021
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19, , , et al.
Pageof 26